Drugs.com - Clinical Trials

Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600

DEER PARK, Ill., March 14, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare...

Mar 18, 2025 - 01:11
 0
Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600
DEER PARK, Ill., March 14, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare...
Read More

Tags:

Previous Article

Zentalis Pharmaceuticals Presents Updated Azenosertib Clinical Data at the Socie...

Next Article

Vivani Medical Achieves First Implant and Full Enrollment in the First-in-Human ...

Related Posts

March Biosciences Receives FDA Orphan Drug Designation for MB-105, a First-in-Class CD5 CAR-T Cell Therapy, for T-Cell Lymphoma

March Biosciences Receives FDA Orphan Drug Designation ...

Feb 9, 2025  0

Tris Pharma Announces Positive Results from ALLEVIATE-1 Phase 3 Clinical Trial of Cebranopadol, an Investigational First-in-Class Oral Dual-NMR Agonist, for the Treatment of Moderate-to-Severe Acute Pain

Tris Pharma Announces Positive Results from ALLEVIATE-1...

Feb 9, 2025  0

Vertex Announces Results From Phase 2 Study of Suzetrigine for the Treatment of Painful Lumbosacral Radiculopathy

Vertex Announces Results From Phase 2 Study of Suzetrig...

Feb 9, 2025  0